Target
Bcl2-associated agonist of cell death
Ligand
BDBM50324474
Substrate
n/a
Meas. Tech.
ChEMBL_650244 (CHEMBL1219942)
IC50
1760±n/a nM
Citation
 Yan, FCao, XXJiang, HXZhao, XLWang, JYLin, YHLiu, QLZhang, CJiang, BGuo, F A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer. J Med Chem 53:5502-10 (2010) [PubMed]  Article 
Target
Name:
Bcl2-associated agonist of cell death
Synonyms:
BAD | BAD_HUMAN | BBC6 | BCL2L8 | Bcl-2-binding component 6 | Bcl-2-like protein 8 | Bcl-XL/Bcl-2-associated death promoter | Bcl2 antagonist of cell death | Bcl2-L-8 | Bcl2-antagonist of cell death (BAD)
Type:
PROTEIN
Mol. Mass.:
18393.69
Organism:
Homo sapiens (Human)
Description:
ChEMBL_478760
Residue:
168
Sequence:
MFQIPEFEPSEQEDSSSAERGLGPSPAGDGPSGSGKHHRQAPGLLWDASHQQEQPTSSSHHGGAGAVEIRSRHSSYPAGTEDDEGMGEEPSPFRGRSRSAPPNLWAAQRYGRELRRMSDEFVDSFKKGLPRPKSAGTATQMRQSSSWTRVFQSWWDRNLGRGSSAPSQ
  
Inhibitor
Name:
BDBM50324474
Synonyms:
CHEMBL1215012 | sodium(2S,2'S,5R,5'R,6R,6'R)-6,6'-((1E,1'E)-(6,6',7,7'-tetrahydroxy-5,5'-diisopropyl-3,3'-dimethyl-1,1',4,4'-tetraoxo-1,1',4,4'-tetrahydro-2,2'-binaphthyl-8,8'-diyl)bis(methan-1-yl-1-ylidene)bis(azan-1-yl-1-ylidene))bis(3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate)
Type:
Small organic molecule
Emp. Form.:
C46H44N4O14S2
Mol. Mass.:
940.991
SMILES:
CC(C)=c1c(O)c(O)c(C=N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C([O-])=O)c2c(O)c(-c3c(O)c4c(C=N[C@H]5[C@H]6SC(C)(C)[C@@H](N6C5=O)C([O-])=O)c(O)c(O)c(=C(C)C)c4c(O)c3=C)c(=C)c(O)c12 |r,w:33.34,9.8,wU:12.18,36.44,11.10,35.36,wD:41.48,17.22,(27.06,.19,;28.39,-.58,;29.73,.19,;28.4,-2.12,;29.73,-2.89,;31.06,-2.12,;29.73,-4.43,;31.06,-5.2,;28.4,-5.2,;28.4,-6.74,;29.73,-7.51,;29.73,-9.05,;30.82,-10.13,;32.18,-10.83,;31.94,-12.35,;32.32,-13.82,;33.48,-12.34,;30.43,-12.59,;29.73,-11.22,;28.64,-10.13,;27.1,-10.13,;29.64,-13.91,;28.1,-13.89,;30.4,-15.25,;27.07,-4.43,;25.74,-5.2,;25.74,-6.74,;24.41,-4.43,;23.08,-5.21,;21.74,-4.45,;21.73,-2.91,;20.41,-5.23,;19.07,-4.46,;19.06,-2.92,;17.73,-2.15,;17.72,-.61,;16.62,.46,;15.24,1.14,;15.47,2.67,;14.13,3.45,;15.45,4.22,;16.99,2.92,;17.7,1.56,;18.8,.47,;20.34,.47,;17.78,4.24,;17.03,5.58,;19.32,4.22,;17.75,-5.23,;16.41,-4.46,;17.74,-6.77,;16.41,-7.54,;19.07,-7.54,;19.08,-9.08,;17.74,-9.86,;20.41,-9.85,;20.42,-6.77,;21.75,-7.54,;21.75,-9.08,;23.08,-6.76,;24.42,-7.53,;24.39,-2.9,;23.05,-2.14,;25.73,-2.13,;25.72,-.59,;27.07,-2.89,)|
Structure:
Search PDB for entries with ligand similarity: